Hospital admission patterns in adult patients with skin and soft tissue infections: Identification of potentially avoidable hospital admissions through a retrospective database analysis

References

• Moran GJ, Abrahamian FM, Lovecchio F, Talan DA. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. J Emerg Med 2013;44:e397–412
   PubMedGoogle Scholar
• Corey GR, Stryjewski ME. New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good. Clin Infect Dis 2011;52:S469–76
   PubMed Web of Science ®Google Scholar
• Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009;15:1516–18
   PubMed Web of Science ®Google Scholar
• Pallin DJ, Espinola JA, Leung DY, Hooper DC, Camargo CA. Epidemiology of dermatitis and skin infections in United States physicians’ offices, 1993-2005. Clin Infect Dis 2009;49:901–7
   PubMed Web of Science ®Google Scholar
• Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008;51:291–8
   PubMed Web of Science ®Google Scholar
• LaPensee K, Fan W. Economic burden of hospitalization with antibiotic treatment for ABSSSI in the US: an analysis of the Premier Hospital Database. 17th Annual International Meeting of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington DC; 2012
   Google Scholar
• Sulham K, LaPensee K, Fan W, Lodise TP. Severity and costs of acute bacterial skin and skin structure infections by treatment setting: an application of the Eron classification to a real-world database. Value Health 2014. 17(3):A282. Available from http://dx.doi.org/10.1016/j.jval.2014.03.1642
   Google Scholar
• Martone WJ, Lindfield KC, Katz DE. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry. Int J Clin Pract 2008;62:1183–7
   PubMed Web of Science ®Google Scholar
• Gesser RM, McCarroll KA, Woods GL. Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections. J Infect 2004;48:32–8
   PubMed Web of Science ®Google Scholar
• Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 2010;51:S198–208
   PubMed Web of Science ®Google Scholar
• Lane MA, Marschall J, Beekmann SE, Polgreen PM, Banerjee R, Hersh AL, Babcock HM. Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians. Infect Control Hosp Epidemiol 2014;35:839–44
   PubMed Web of Science ®Google Scholar
• Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: Expert Panel recommendations on key decision points. J Antimicrob Chemother 2003;52:i3–17
   PubMedGoogle Scholar
• Marwick C, Broomhall J, McCowan C, Phillips G, Gonzalez-McQuire S, Akhras K, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011;66:387–97
   PubMed Web of Science ®Google Scholar
• Clinical Resource Efficiency Support Team (CREST). CREST Guidelines on the Management of Cellulitis in Adults. DHSS Northern Ireland 2005;1–31
   Google Scholar
• Pollack CV, Amin A, Ford WT, Finley R, Kaye KS, Nguyen HH, et al. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital. J Emerg Med 2015;48:508–19
   PubMed Web of Science ®Google Scholar
• Marwick C, Rae N, Irvine N, Davey P. Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. J Antimicrob Chemother 2012;67:1016–19
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003;56:221–9
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality 2012. National statistics: outcomes for multiple specific diagnoses 2014. Available from http://hcupnet.ahrq.gov
   Google Scholar
• Nathwani D, Eckmann C, Lawson W, Stephens JM, Macahilig C, Solem CT, et al. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clin Microbiol Infect 2014;20:993–1000
   PubMed Web of Science ®Google Scholar
• Talan DA, Salhi BA, Moran GJ, Mower WR, Hsieh YH, Krishnadasan A, Rothman RE. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med 2015;16:89–97
   PubMed Web of Science ®Google Scholar
• Seaton RA, Barr DA. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Intern Med 2013;24:617–23
   PubMed Web of Science ®Google Scholar
• Yong C, Fisher DA, Sklar GE, Li SC. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. Int J Antimicrob Agents 2009;33:46–51
   PubMed Web of Science ®Google Scholar
• Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009;64:1316–24
   PubMed Web of Science ®Google Scholar
• Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651–72
   PubMed Web of Science ®Google Scholar
• Corey GR, Good S, Jiang H, Moeck G, Wikler M, Green S, et al. Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study. Clin Infect Dis 2015;60:254–62
   PubMed Web of Science ®Google Scholar
• Corey GR, Kabler H, Mehra P, Gupta S, Overcash JS, Porwal A, et al. Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med 2014;370:2180–90
   PubMed Web of Science ®Google Scholar
• Schrock JW, Laskey S, Cydulka RK. Predicting observation unit treatment failures in patients with skin and soft tissue infections. Int J Emerg Med 2008;1:85–90
   PubMedGoogle Scholar
• Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ. Acute bacterial skin and skin structure infections treated with intravenous antibiotics in the emergency department or observational unit: experience at the Detroit medical center. Infect Dis Ther 2015;4:173–86
   PubMedGoogle Scholar